Related references
Note: Only part of the references are listed.Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review
A. D. Andersen et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models
Alain D. Dekker et al.
NEUROBIOLOGY OF DISEASE (2017)
Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story
Yannick Vermeiren et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Cognitive function in the early phase of Parkinson's disease, a five-year follow-up
M. E. Domellof et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Serotonin in Parkinson's disease
Marios Polotis et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines
Andrew F. Fischer et al.
NEUROCHEMICAL RESEARCH (2015)
The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease
Yannick Vermeiren et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis
Sylvie Slaets et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2015)
CSF biomarkers and clinical progression of Parkinson disease
Sara Hall et al.
NEUROLOGY (2015)
Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias
Megan K. Herbert et al.
ALZHEIMERS & DEMENTIA (2014)
Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic amines and metabolites in human brain tissue
Debby Van Dam et al.
JOURNAL OF CHROMATOGRAPHY A (2014)
Serotonin Impairment in CSF of PD Patients, without an Apparent Clinical Counterpart
Enrica Olivola et al.
PLOS ONE (2014)
Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia
Yannick Vermeiren et al.
ALZHEIMERS & DEMENTIA (2013)
Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia
Kelly Del Tredici et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Progression of monoaminergic dysfunction in Parkinson's disease: A longitudinal 18F-dopa PET study
Nicola Pavese et al.
NEUROIMAGE (2011)
Noradrenaline and Parkinson's disease
Claire Delaville et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2011)
CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease
A. Siderowf et al.
NEUROLOGY (2010)
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
Sebastiaan Engelborghs et al.
NEUROBIOLOGY OF AGING (2008)
Cortical Lewy body disease and Parkinson's disease dementia
David J. Burn
CURRENT OPINION IN NEUROLOGY (2006)
Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies
P Szot et al.
JOURNAL OF NEUROSCIENCE (2006)
Cognitive profile of patients with newly diagnosed Parkinson disease
D Muslimovic et al.
NEUROLOGY (2005)
Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease
S Engelborghs et al.
NEUROCHEMICAL RESEARCH (2003)
The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
CW Berridge et al.
BRAIN RESEARCH REVIEWS (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Cardiac sympathetic denervation in Parkinson disease
DS Goldstein et al.
ANNALS OF INTERNAL MEDICINE (2000)
Role of serotonin in memory impairment
HC Buhot et al.
ANNALS OF MEDICINE (2000)
Share Paper
